Wells Fargo’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.9M | Buy |
|
|||||
|
2025
Q2 | $1.21M | Sell |
|
|||||
|
2025
Q1 | $1.47M | Buy |
|
|||||
|
2024
Q4 | $259K | Buy |
|
|||||
|
2024
Q3 | $156K | Sell |
|
|||||
|
2024
Q2 | $655K | Buy |
|
|||||
|
2024
Q1 | $1.47M | Buy |
|
|||||
|
2023
Q4 | $209K | Buy |
|
|||||
|
2023
Q3 | $66.2K | Sell |
|
|||||
|
2023
Q2 | $113K | Buy |
|
|||||
|
2023
Q1 | $14.1K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $105K | Sell |
|
|||||
|
2021
Q4 | $195K | Sell |
|
|||||
|
2021
Q3 | $615K | Buy |
|
|||||
|
2021
Q2 | $23K | Buy |
|
|||||
|
2021
Q1 | $25K | Buy |
|
|||||
|
2020
Q4 | $15K | Sell |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $108K | Sell |
|
|||||
|
2020
Q1 | $202K | Buy |
|
|||||
|
2019
Q4 | $287K | Buy |
|
|||||
|
2019
Q3 | $316K | Buy |
|
|||||
|
2019
Q2 | $159K | Buy |
|
|||||
|
2019
Q1 | $92K | Sell |
|
|||||
|
2018
Q4 | $99K | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $3K | Hold |
|
|||||
|
2016
Q2 | $3K | Hold |
|
|||||
|
2016
Q1 | $3K | Buy |
|